ArticleAmerican journal of translational research2021
The efficacy and safety of radiofrequency ablation on the platelet activation and the inflammatory response in elderly atrial fibrillation patients.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) is the most common type of arrhythmia. AF is more common in the elderly population than in the young population. Radiofrequency ablation (RA) is the treatment option for drug-naïve AF; however, previous studies have focused on the young population. Therefore, it would be clinically valuable to compare the efficacy and safety of RA in both elderly and young patients with AF.
objectiveThis study intended to compare the efficacy and safety of RA in elderly and young patients with AF.
methodsForty patients with drug-naïve AF who underwent RA at our hospital were retrospectively evaluated, of whom 20 were < 65 years old (group 1) and 20 were ≥ 65 years old (group 2). The treatment efficacy was evaluated by comparing the durations of the surgical procedures, the postoperative platelet activation, and the inflammatory factor levels.
resultsThe total operation times for RA (160.64 ± 7.25 vs. 160.64 ± 7.25 min,
conclusionRA is a safe and effective procedure in elderly and young patients with medically refractory AF.
Indexed as
Identifiers
34540116PMC8430126What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.